Skip to content

CHICAGO–(BUSINESS WIRE)–June 29, 2004–Allscripts Healthcare
Solutions, Inc. (NASDAQ:MDRX) announced today that it has entered into
an agreement with initial purchasers to sell $75 million aggregate
principal amount of its 3.50% Convertible Senior Debentures Due 2024
in a previously announced private placement pursuant to Rule 144A of
the Securities Act of 1933, as amended. In addition, the Company has
granted the initial purchasers of the debentures an option to purchase
up to an additional $7.5 million aggregate principal amount of
debentures. The offering is expected to close on or about July 6,
2004, subject to customary closing conditions.

The debentures will mature on July 15, 2024 and will be
convertible, under certain circumstances, into shares of the Company’s
common stock at a conversion rate of 88.8415 shares per $1,000
principal amount of debentures (equivalent to an initial conversion
price of $11.256 per share), subject to adjustment in certain

The Company intends to use the net proceeds to repurchase
approximately $11.25 million of its common stock that it expects will
be sold by purchasers of the debentures and for general corporate
purposes, which may include future additional share repurchases,
acquisitions or other strategic investments.

This news release does not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of the
debentures or the common stock issuable upon conversion of the
debentures in any state in which such offer, solicitation or sale
would be unlawful. The debentures have been offered to qualified
institutional buyers in reliance on Rule 144A under the Securities Act
of 1933, as amended. The debentures and the common stock issuable upon
conversion of the debentures have not been registered under the
Securities Act, and unless so registered, may not be offered or sold
in the United States except pursuant to an exemption from, or in a
transaction not subject to, the registration requirements of the
Securities Act and applicable state securities laws.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions (AHS) is the leading provider of
clinical software, connectivity and information solutions for
physicians. The Company’s TouchWorks(TM) software is a modular
Electronic Medical Record (EMR) that enhances physician productivity
by automating the most common physician activities including
prescribing, dictating, capturing charges, ordering labs and viewing
results, providing patient education, and documenting clinical
encounters. TouchWorks is available on the latest Tablet PCs, wireless
handheld devices, desktop workstations and over the Internet. AHS also
offers electronic document imaging and scanning solutions through its
Advanced Imaging Concepts subsidiary. Additionally, AHS provides
healthcare product education and market research programs for
physicians through its Physicians Interactive(TM) unit and medication
fulfillment services through its Allscripts Direct(TM) unit. Visit AHS
on the Web at

This announcement may contain forward-looking statements about
Allscripts Healthcare Solutions that involve risks and uncertainties.
These statements are developed by combining currently available
information with Allscripts’ beliefs and assumptions. Forward-looking
statements do not guarantee future performance. Because Allscripts
cannot predict all of the risks and uncertainties that may affect it,
or control the ones it does predict, Allscripts’ actual results may be
materially different from the results expressed in its forward-looking
statements. For a more complete discussion of the risks, uncertainties
and assumptions that may affect Allscripts see the Company’s 2003
Annual Report on Form 10-K, available through the Web site maintained
by the Securities and Exchange Commission at

    CONTACT: Allscripts Healthcare Solutions, Inc.
             Bill Davis, 847-680-3515, Ext. 282
             Lee Shapiro, 847-680-3515, Ext. 4275

    SOURCE: Allscripts Healthcare Solutions, Inc.
Scroll To Top